Cronos (CRON) FCF Payout Ratio (2020 - 2025)
Cronos (CRON) posted quarterly FCF Payout Ratio of 0.26 for Q4 2025, up 106.96% quarter-over-quarter from 3.79 in Q2 2025.
Cronos (CRON) FCF Payout Ratio (2020 - 2025) Analysis & Trends
Cronos' FCF Payout Ratio history runs 3 years deep, the most recent figure standing at 0.26 for Q4 2025.
- In Q4 2025, FCF Payout Ratio changed N/A year-over-year to 0.26; the TTM figure through Dec 2025 stood at 19.72 (up 10333.4% YoY), while the FY2025 annual figure was 43.04, changed N/A from the prior year.
- FCF Payout Ratio for Q4 2025 stood at 0.26, up from 3.79 in the prior quarter.
- The five-year high for FCF Payout Ratio was 0.26 in Q4 2025, with the low at 3.79 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.41 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -0.83 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.42 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Cronos | 1.20 Bn | 407.87 Mn | 28.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.26 |
| Jun 30, 2025 | -3.79 |
| Dec 31, 2022 | -0.02 |
| Dec 31, 2020 | -0.02 |